Skip to main content
Literatur
2.
Zurück zum Zitat Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma [Internet]. Thyroid. 2015:567–610.CrossRef Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma [Internet]. Thyroid. 2015:567–610.CrossRef
3.
Zurück zum Zitat Bortot DC, Amorim BJ, Oki GC, Gapski SB, Santos AO, Lima MCL, et al. 18F-fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy. Eur J Nucl Med Mol Imaging. 2012;39:1730–6.CrossRef Bortot DC, Amorim BJ, Oki GC, Gapski SB, Santos AO, Lima MCL, et al. 18F-fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy. Eur J Nucl Med Mol Imaging. 2012;39:1730–6.CrossRef
4.
Zurück zum Zitat Beheshti M, Mottaghy FM, Paycha F, Behrendt FFF, Van den Wyngaert T, Fogelman I, et al. (18) F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging. 2015;42:1767–77.CrossRef Beheshti M, Mottaghy FM, Paycha F, Behrendt FFF, Van den Wyngaert T, Fogelman I, et al. (18) F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging. 2015;42:1767–77.CrossRef
5.
Zurück zum Zitat Krüger S, Buck AK, Mottaghy FM, Hasenkamp E, Pauls S, Schumann C, et al. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:1807–12.CrossRef Krüger S, Buck AK, Mottaghy FM, Hasenkamp E, Pauls S, Schumann C, et al. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:1807–12.CrossRef
6.
Zurück zum Zitat Basu S, Ranade R, Thapa P. 177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT aid in personalized treatment decision making in selecting the best therapeutic option? Nucl Med Commun. 2016;37:100–2.CrossRef Basu S, Ranade R, Thapa P. 177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT aid in personalized treatment decision making in selecting the best therapeutic option? Nucl Med Commun. 2016;37:100–2.CrossRef
7.
Zurück zum Zitat Duarte PS, de Castroneves LA, Sado HN, Sapienza MT, de Oliveira Hoff AAF, Buchpiguel CA. Bone and calcified soft tissue metastases of medullary thyroid carcinoma better characterized on F-fluoride PET/CT than on Ga-DOTATATE PET/CT. Nucl Med Mol Imaging. 2018;52:318–23.CrossRef Duarte PS, de Castroneves LA, Sado HN, Sapienza MT, de Oliveira Hoff AAF, Buchpiguel CA. Bone and calcified soft tissue metastases of medullary thyroid carcinoma better characterized on F-fluoride PET/CT than on Ga-DOTATATE PET/CT. Nucl Med Mol Imaging. 2018;52:318–23.CrossRef
8.
Zurück zum Zitat do Vale RH, Marin JF, Duarte PS, Sapienza MT, Buchpiguel CA. Visualization of lymph nodal and hepatic metastases of medullary thyroid carcinoma on 18F-fluoride PET/CT. Clin Nucl Med. 2015;40:895–6. do Vale RH, Marin JF, Duarte PS, Sapienza MT, Buchpiguel CA. Visualization of lymph nodal and hepatic metastases of medullary thyroid carcinoma on 18F-fluoride PET/CT. Clin Nucl Med. 2015;40:895–6.
9.
Zurück zum Zitat Duarte PS, Marin JFG, Filho GBC, Sapienza MT, Buchpiguel CA. 18F-fluoride uptake in soft tissue metastases of medullary thyroid carcinoma as a marker of progressive calcification. Clin Nucl Med. 2018;43:848–9.CrossRef Duarte PS, Marin JFG, Filho GBC, Sapienza MT, Buchpiguel CA. 18F-fluoride uptake in soft tissue metastases of medullary thyroid carcinoma as a marker of progressive calcification. Clin Nucl Med. 2018;43:848–9.CrossRef
Metadaten
Titel
Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
verfasst von
Paulo Schiavom Duarte
Publikationsdatum
18.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04556-5

Weitere Artikel der Ausgabe 3/2020

European Journal of Nuclear Medicine and Molecular Imaging 3/2020 Zur Ausgabe